Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH1C | P00326 | 3/20 | 0.38 |
| ▸ | ADH1A | P07327 | 3/20 | 0.38 |
| ▸ | ADH1B | P00325 | 2/20 | 0.38 |
| ▸ | ADH4 | P08319 | 1/20 | 0.38 |
| ▸ | ADH7 | P40394 | 1/20 | 0.38 |
| ▸ | CTSK | P43235 | 8/20 | 0.35 |
| ▸ | CTSL | P07711 | 5/20 | 0.35 |
| ▸ | CTSB | P07858 | 5/20 | 0.35 |
| ▸ | CTSH | P09668 | 3/20 | 0.33 |
| ▸ | LTA4H | P09960 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24601 | 0.98 | ADH1B (0.34) | ADH1CADH1AADH1BADH4ADH7 | |
| SCHEMBL18664140 | 0.89 | — | — | |
| SCHEMBL7879516 | 0.80 | METAP1 (0.41) | ADH1CADH1AADH1BADH4ADH7 | |
| SCHEMBL3155857 | 0.79 | CYP1A2 (0.40) | CTSKCTSLCTSBCTSHLTA4H | |
| SCHEMBL6748871 | 0.79 | CTSK (0.32) | CTSKCTSLCTSB | |
| SCHEMBL6564265 | 0.78 | METAP1 (0.38) | ADH1CADH1AADH1BADH4ADH7 | |
| SCHEMBL15173337 | 0.76 | CTSK (0.37) | ADH1CADH1AADH1BADH4ADH7 | |
| SCHEMBL28022207 | 0.76 | CYP1A2 (0.42) | — | |
| Propionaldehyde SCHEMBL27200261 | 0.75 | CTSK (0.38) | ADH1CADH1AADH1BADH4ADH7 | |
| SCHEMBL21008653 | 0.75 | ADH1B (0.38) | ADH1CADH1AADH1BADH4ADH7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107254358-A | Synthesis of flavoring agent | 卡达·拉梅什·瓦兹 | 2017-10-17 | — | — | CN | claimed |
| CN-103210074-B | Synthesis of flavoring agent | 卡达·拉梅什·瓦兹 | 2017-03-29 | — | — | CN | claimed |
| EP-2609184-B1 | PERFUMERY COMPOSITIONS AND SYNTHESIS OF A ODORANT | VAZE KEDAR RAMESH (IN) | 2017-02-15 | — | — | EP | claimed |
| CN-103210074-A | Synthesis of a novel odorant | VAZE KEDAR RAMESH | 2013-07-17 | — | — | CN | claimed |
| EP-2609184-A1 | SYNTHESIS OF A NOVEL ODORANT | Vaze, Kedar Ramesh (IN) | 2013-07-03 | — | — | EP | claimed |
| US-20130157923-A1 | SYNTHESIS OF A NOVEL ODORANT | VAZE KEDAR RAMESH (IN) | 2013-06-20 | — | — | US | claimed |
| WO-2012025934-A1 | SYNTHESIS OF A NOVEL ODORANT | VAZE KEDAR RAMESH (IN) | 2012-03-01 | — | — | WO | claimed |
| US-11655216-B2 | Aryl and heteroaryl ether derivatives as liver X receptor beta agonists, compositions, and their use | MERCK SHARP & DOHME LLC (US) | 2023-05-23 | — | — | US | disclosed |
| EP-3556781-A1 | RESIN, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN | Sumitomo Chemical Company, Limited (JP) | 2019-10-23 | — | — | EP | disclosed |
| US-9845443-B2 | Synthesis of a novel odorant | VAZE KEDAR RAMESH (IN) | 2017-12-19 | — | — | US | disclosed |
| US-9845443-B2 | Synthesis of a novel odorant | VAZE KEDAR RAMESH (IN) | 2017-12-19 | — | — | US | disclosed |
| US-9845443-B2 | Synthesis of a novel odorant | VAZE KEDAR RAMESH (IN) | 2017-12-19 | — | — | US | disclosed |
| CN-107254358-A | Synthesis of flavoring agent | 卡达·拉梅什·瓦兹 | 2017-10-17 | — | — | CN | disclosed |
| CN-103210074-A | Synthesis of a novel odorant | VAZE KEDAR RAMESH | 2013-07-17 | — | — | CN | disclosed |
| EP-2609184-A1 | SYNTHESIS OF A NOVEL ODORANT | Vaze, Kedar Ramesh (IN) | 2013-07-03 | — | — | EP | disclosed |
| US-20130157923-A1 | SYNTHESIS OF A NOVEL ODORANT | VAZE KEDAR RAMESH (IN) | 2013-06-20 | — | — | US | disclosed |
| US-20130157923-A1 | SYNTHESIS OF A NOVEL ODORANT | VAZE KEDAR RAMESH (IN) | 2013-06-20 | — | — | US | disclosed |
| US-20130157923-A1 | SYNTHESIS OF A NOVEL ODORANT | VAZE KEDAR RAMESH (IN) | 2013-06-20 | — | — | US | disclosed |
| WO-2012025934-A1 | SYNTHESIS OF A NOVEL ODORANT | VAZE KEDAR RAMESH (IN) | 2012-03-01 | — | — | WO | disclosed |
| WO-2012025934-A1 | SYNTHESIS OF A NOVEL ODORANT | VAZE KEDAR RAMESH (IN) | 2012-03-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11655216-B2 | Aryl and heteroaryl ether derivatives as liver X receptor beta agonists, compositions, and their use | NR1H2, NR1H3, NR1H4 | ADH1C 848/4885ADH1A 582/4885ADH1B 1034/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.